Because of the activity of chemotactic protein stromal cell derived factor 1 (SDF-1) and its receptor CXC chemokine receptor 4 (CXCR4), BMSCs have the ability for automatic homing on the infarction area after transplantation [7–9], significantly facilitating the treatment of cardiovascular disease. Here, CXCL12 is linked to cardiovascular disorder.